Ailawadhi S - Search Results

1

Trends in the Risks of Secondary Cancers in Patients With Hodgkin Lymphoma.

Kumar V, Garg M, Chandra AB, Mayorga VS, Ahmed S, Ailawadhi S. Kumar V, et al. Among authors: ailawadhi s. Clin Lymphoma Myeloma Leuk. 2018 Sep;18(9):576-589.e1. doi: 10.1016/j.clml.2018.05.021. Epub 2018 May 30. Clin Lymphoma Myeloma Leuk. 2018. PMID: 29934060

2

Variable risk of second primary malignancy in multiple myeloma patients of different ethnic subgroups.

Ailawadhi S, Swaika A, Razavi P, Yang D, Chanan-Khan A. Ailawadhi S, et al. Blood Cancer J. 2014 Sep 5;4(9):e243. doi: 10.1038/bcj.2014.63. Blood Cancer J. 2014. PMID: 25192415 Free PMC article.

3

Persistent Disparities Among Patients With T-Cell Non-Hodgkin Lymphomas and B-Cell Diffuse Large Cell Lymphomas Over 40 Years: A SEER Database Review.

Crozier JA, Sher T, Yang D, Swaika A, Foran J, Ghosh R, Tun H, Colon-Otero G, Kelly K, Chanan-Khan A, Ailawadhi S. Crozier JA, et al. Among authors: ailawadhi s. Clin Lymphoma Myeloma Leuk. 2015 Oct;15(10):578-85. doi: 10.1016/j.clml.2015.06.005. Epub 2015 Jun 19. Clin Lymphoma Myeloma Leuk. 2015. PMID: 26198444 Free PMC article.

4

Second primary acute lymphoblastic leukemia in adults: a SEER analysis of incidence and outcomes.

Swaika A, Frank RD, Yang D, Finn LE, Jiang L, Advani P, Chanan-Khan AA, Ailawadhi S, Foran JM. Swaika A, et al. Among authors: ailawadhi s. Cancer Med. 2018 Feb;7(2):499-507. doi: 10.1002/cam4.1266. Epub 2017 Dec 28. Cancer Med. 2018. PMID: 29282894 Free PMC article.

5

Ibrutinib for the Management of Schnitzler Syndrome: A Novel Therapy for a Rare Condition.

Jani P, Vissing MB, Ahmed S, Sluzevich JC, Aulakh S, Alegria V, Ailawadhi M, Chanan-Khan A, Ailawadhi S. Jani P, et al. Among authors: ailawadhi s, ailawadhi m. J Oncol Pract. 2018 Jun;14(6):387-388. doi: 10.1200/JOP.18.00050. Epub 2018 Mar 20. J Oncol Pract. 2018. PMID: 29558252 Free PMC article. No abstract available.

6

Impact of psychiatric comorbidities on health care utilization and cost of care in multiple myeloma.

Niazi S, Frank RD, Sharma M, Roy V, Ames S, Rummans T, Spaulding A, Sher T, Ailawadhi M, Bhatia K, Ahmed S, Tan W, Chanan-Khan A, Ailawadhi S. Niazi S, et al. Among authors: ailawadhi s, ailawadhi m. Blood Adv. 2018 May 22;2(10):1120-1128. doi: 10.1182/bloodadvances.2018016717. Blood Adv. 2018. PMID: 29776984 Free PMC article.

7

Marantic Endocarditis Associated With T-Cell Large Granular Lymphocytic Leukemia: First Report of Its Occurrence With a Lymphoproliferative Malignancy in Adults.

Ahmed S, Jani P, Yamani MH, Ailawadhi S, Alegria VR, Ailawadhi M. Ahmed S, et al. Among authors: ailawadhi s, ailawadhi m. J Oncol Pract. 2018 Oct;14(10):625-627. doi: 10.1200/JOP.18.00168. Epub 2018 Sep 17. J Oncol Pract. 2018. PMID: 30222473 No abstract available.

8

A Phase I Study to Assess the Safety and Pharmacokinetics of Single-agent Lorvotuzumab Mertansine (IMGN901) in Patients with Relapsed and/or Refractory CD-56-positive Multiple Myeloma.

Ailawadhi S, Kelly KR, Vescio RA, Jagannath S, Wolf J, Gharibo M, Sher T, Bojanini L, Kirby M, Chanan-Khan A. Ailawadhi S, et al. Clin Lymphoma Myeloma Leuk. 2019 Jan;19(1):29-34. doi: 10.1016/j.clml.2018.08.018. Epub 2018 Sep 5. Clin Lymphoma Myeloma Leuk. 2019. PMID: 30340993 Free PMC article. Clinical Trial.

9

Retreatment with obinutuzumab: An addition to the therapeutic landscape of chronic lymphocytic leukemia.

Khurana S, Ahmed S, Alegria VR, Aulakh S, Ailawadhi M, Singh A, Chanan-Khan A, Ailawadhi S. Khurana S, et al. Among authors: ailawadhi s, ailawadhi m. SAGE Open Med Case Rep. 2019 Jan 16;7:2050313X18823917. doi: 10.1177/2050313X18823917. eCollection 2019. SAGE Open Med Case Rep. 2019. PMID: 30728976 Free PMC article.

10

Indatuximab Ravtansine (BT062) Monotherapy in Patients With Relapsed and/or Refractory Multiple Myeloma.

Jagannath S, Heffner LT Jr, Ailawadhi S, Munshi NC, Zimmerman TM, Rosenblatt J, Lonial S, Chanan-Khan A, Ruehle M, Rharbaoui F, Haeder T, Wartenberg-Demand A, Anderson KC. Jagannath S, et al. Among authors: ailawadhi s. Clin Lymphoma Myeloma Leuk. 2019 Jun;19(6):372-380. doi: 10.1016/j.clml.2019.02.006. Epub 2019 Feb 21. Clin Lymphoma Myeloma Leuk. 2019. PMID: 30930134

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

199 results

Search Page